Quarterly return is Gross Profit / Starting Portfolio value. Prior to that, he worked among others at JP Morgan, where he held a number of executive roles in Europe, Asia and the US.The inaugural International Investment London Forum will look at where the industry is heading, the challenges and opportunities for the industry in the region, and how advisers, brokers and product providers are adapting to political and regulatory changes.The event will take place on Thursday, 30th April at the South Place Hotel, London.Rotterdam-based Robeco Institutional Asset Management has appointed Gilbert Van Hassel as CEO and chairman of the management board as of 19 September. This represents a change in shares of -0.77 percent and a change in value of -0.59 percent during the quarter. The institutional investor owned 50,598 shares of the industrial products company’s stock after selling 41,400 shares during the period. See G O J M Van Hassel's compensation, career history, education, & memberships.
Robeco encourages good governance and sustainable corporate practices, which contribute to long-term shareholder value creation. The firm owned 374,495 shares of the financial services provider’s stock after selling 342,891 shares during the period. Van Hassel joins from former ING Investment Management, now NN IP, where he most recently held the positins of global CEO ING Investment Management and member of the Board Insurance and Asset Management. Identify and filter trades that are part of a predefined automatic trading plan.Robeco Institutional Asset Management B.V. reports 0.77% decrease in ownership of PFIZER / Pfizer LtdJuly 20, 2020- Robeco Institutional Asset Management B.V. has filed a 13F-HR form disclosing ownership of 7,194,813shares of Pfizer Ltd (IN:PFIZER)with total holdings valued at $235,272,000 USD as of June 30, 2020.Robeco Institutional Asset Management B.V. had filed a previous 13F-HR on April 30, 2020 disclosing7,250,679 shares of Pfizer Ltd at a value of $236,665,000 USD.This represents a change in shares of -0.77 percent and a change in value of -0.59 percentduring the quarter.The Security, Class, and ID columns in the table below are shown exactly as filed by the investor.We do our best to track continuity of investments through acquisitions, and this will be reflected inthe table as changes in names and CUSIPs. Robeco Institutional Asset Management B.V. of the Netherlands operates as an investment management company. It is a privilege to become part of an organization that offers high quality service and proven, innovative investment solutions to clients all over the world. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then usethat to calculate gross profit. The Security, Class, and ID columns in the table below are shown exactly as filed by the investor. Robeco Institutional Asset Management B.V. had filed a previous 13F-HR on April 30, 2020 disclosing 7,250,679 shares of Pfizer Ltd at a value of $236,665,000 USD.